DEFB1 and chronic kidney disease: Nevertheless, a Chinese compound (Shen Qi Wan (SQW)) consisting of eight Chinese herbs can activate AQP1 and β-defensin 1 (DEFB1), leading to a reduction in the inflammatory response after adenine treatment [12], indicating a potential therapeutic option of restoring AQP1 expression in CKD.